BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 15888706)

  • 1. Implantable cardioverter-defibrillators.
    Mack MJ
    N Engl J Med; 2005 May; 352(19):2022-5; author reply 2022-5. PubMed ID: 15888706
    [No Abstract]   [Full Text] [Related]  

  • 2. Implantable cardioverter-defibrillators.
    Nash I
    N Engl J Med; 2005 May; 352(19):2022-5; author reply 2022-5. PubMed ID: 15892195
    [No Abstract]   [Full Text] [Related]  

  • 3. Implantable cardioverter defibrillators: an excellent case study.
    Stanton MS
    Health Aff (Millwood); 2005; 24(1):52-4. PubMed ID: 15647215
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Medicare coverage of ICDs.
    McClellan MB; Tunis SR
    N Engl J Med; 2005 Jan; 352(3):222-4. PubMed ID: 15659721
    [No Abstract]   [Full Text] [Related]  

  • 5. Shock treatment. Medicare's coverage of implantable defibrillators adds jolt to electrophysiology specialty, device sales.
    Becker C
    Mod Healthc; 2005 May; 35(19):34, 36. PubMed ID: 15929257
    [No Abstract]   [Full Text] [Related]  

  • 6. Medicare coverage for technological innovations--time for new criteria?
    Gillick MR
    N Engl J Med; 2004 May; 350(21):2199-203. PubMed ID: 15152067
    [No Abstract]   [Full Text] [Related]  

  • 7. Prophylactic defibrillator implantation--toward an evidence-based approach.
    Kadish A
    N Engl J Med; 2005 Jan; 352(3):285-7. PubMed ID: 15659729
    [No Abstract]   [Full Text] [Related]  

  • 8. The Economics of ICDs.
    Jauhar S; Slotwiner DJ
    N Engl J Med; 2004 Dec; 351(24):2542-4. PubMed ID: 15590958
    [No Abstract]   [Full Text] [Related]  

  • 9. Grasping the role of technology: a conversation with Ron Dollens. Interview by John K. Iglehart.
    Dollens R
    Health Aff (Millwood); 2005; Suppl Web Exclusives():W5-296-W5-313. PubMed ID: 15975988
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Preventing sudden death: implantable cardioverter-defibrillators in elderly cardiac patients.
    Groeneveld PW
    LDI Issue Brief; 2008; 13(6):1-4. PubMed ID: 18613344
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Medicare and cost-effectiveness analysis.
    Smolkin MT
    N Engl J Med; 2006 Jan; 354(2):207-9; author reply 207-9. PubMed ID: 16411303
    [No Abstract]   [Full Text] [Related]  

  • 12. Pacemaker indication must meet Medicare coverage determination.
    Hirsch R
    JAMA Intern Med; 2013 Sep; 173(17):1658-9. PubMed ID: 24061394
    [No Abstract]   [Full Text] [Related]  

  • 13. Effectiveness of implantable cardioverter-defibrillators for the primary prevention of sudden cardiac death in women with advanced heart failure: a meta-analysis of randomized controlled trials.
    Ghanbari H; Dalloul G; Hasan R; Daccarett M; Saba S; David S; Machado C
    Arch Intern Med; 2009 Sep; 169(16):1500-6. PubMed ID: 19752408
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Defibrillators in heart failure and quality of life.
    Matlock DD
    N Engl J Med; 2009 Jan; 360(2):187-8; author reply 189. PubMed ID: 19129534
    [No Abstract]   [Full Text] [Related]  

  • 15. Using the MADIT II criteria for implantable cardioverter defibrillators-what is the role of the Food and Drug Administration approval?
    Barold HS
    Card Electrophysiol Rev; 2003 Dec; 7(4):443-6. PubMed ID: 15071272
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cost-effectiveness of ICDs.
    Stevenson LW; Stevenson WG
    N Engl J Med; 2006 Jan; 354(2):205-7; author reply 205-7. PubMed ID: 16411295
    [No Abstract]   [Full Text] [Related]  

  • 17. Expenditure and value for money: the challenge of implantable cardioverter defibrillators.
    Boriani G; Biffi M; Martignani C; Diemberger I; Valzania C; Bertini M; Branzi A
    QJM; 2009 May; 102(5):349-56. PubMed ID: 19276209
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cost-effectiveness of defibrillator therapy or amiodarone in chronic stable heart failure: results from the Sudden Cardiac Death in Heart Failure Trial (SCD-HeFT).
    Mark DB; Nelson CL; Anstrom KJ; Al-Khatib SM; Tsiatis AA; Cowper PA; Clapp-Channing NE; Davidson-Ray L; Poole JE; Johnson G; Anderson J; Lee KL; Bardy GH;
    Circulation; 2006 Jul; 114(2):135-42. PubMed ID: 16818817
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cost-effectiveness of a microvolt T-wave alternans screening strategy for implantable cardioverter-defibrillator placement in the MADIT-II-eligible population.
    Chan PS; Stein K; Chow T; Fendrick M; Bigger JT; Vijan S
    J Am Coll Cardiol; 2006 Jul; 48(1):112-21. PubMed ID: 16814657
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The long-term cost-effectiveness of cardiac resynchronization therapy with or without an implantable cardioverter-defibrillator.
    Yao G; Freemantle N; Calvert MJ; Bryan S; Daubert JC; Cleland JG
    Eur Heart J; 2007 Jan; 28(1):42-51. PubMed ID: 17110403
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.